Comparison of Ranolazine and Trimetazidine on Glycemic Status in Diabetic Patients with Coronary Artery Disease – A Randomized Controlled Trial

Introduction: Cardiovascular diseases have become the leading cause of death around the globe and diabetes mellitus (DM) is considered to be a coronary artery disease (CAD) risk equivalent. Ranolazine, an anti anginal drug has been found to reduce Glycated haemoglobin (HbA(1c)) in diabetes patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Diagn Res
Main Authors: Sandhiya, Selvarajan, Dkhar, Steven Aibor, Pillai, Ajith Ananthakrishna, George, Melvin, Jayaraman, Balachander, Chandrasekaran, Adithan
Formato: Artigo
Idioma:Inglês
Publicado em: JCDR Research and Publications (P) Limited 2015
Assuntos:
Internal Medicine Section
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4347105/
https://ncbi.nlm.nih.gov/pubmed/25738014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2015/10594.5448
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados